Models Exposed

Published Sep 17, 2012
Princeton, NJ, USA – As consumers, we are becoming experts at scrutinizing the reviews our peers write about products we are thinking of buying. We ask ourselves if the comments written in the review truly fit the product, are the comments promotional or too negative, or simply unrelated to the product itself. Health care decision makers are starting to do this with modeling studies. They are asking themselves, “Where is this information coming from? Are the results realistic? Are they relevant to my decision?” Dr. Jaime Caro, co-author on the paper, “Model Transparency and Validation: A Report of the ISPOR-SMDM Modeling Good Research Practices Task Force Working Group-7,” states, “For decision makers to trust the results of models, these must be shown to be valid in the sense of being sufficiently accurate and relevant. This subgroup of the ISPOR-SMDM Modeling Task Force detailed the steps required to ensure the validity of models and grappled with the difficult balance between transparency and protection of intellectual property, proposing a compromise that should provide for full scientific review of models.”  This paper provides guidance for health care researchers to ensure that their models are both transparent and valid. This paper is one of the seven papers in the series on modeling study best practices and is jointly published in Value in Health, the official journal of the International Society for Pharmacoeconomics and Outcomes Research (ISPOR), and Medical Decision Making, the official journal of the Society for Medical Decision Making (SMDM).

Value in Health (ISSN 1098-3015) publishes papers, concepts, and ideas that advance the field of pharmacoeconomics and outcomes research as well as policy papers to help health care leaders make evidence-based decisions. The journal is published bi-monthly and has over 8,000 subscribers (clinicians, decision makers, and researchers worldwide).

International Society for Pharmacoeconomics and Outcomes Research (ISPOR) is a nonprofit, international, educational and scientific organization that strives to increase the efficiency, effectiveness, and fairness of health care resource use to improve health. For more information: www.ispor.org

Related Stories

Rethinking Medication Adherence: A Stakeholder Blueprint

May 12, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced today the publication of a report from its Medication Adherence and Persistence Special Interest Group that provides valuable insights into the perspectives of key stakeholders on interventions to improve medication adherence. The report, “Stakeholders’ Perspectives on Medication Adherence Enhancing Interventions: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

New Research Reveals Surprising Trends in Women's Health Economics Authorship

May 12, 2025

Value in Health, the official journal of ISPOR announced the publication of new research analyzing women's representation in authorship of papers submitted to and published in Value in Health. The report, “How Well Are Women Represented in Authorship in HEOR? An Analysis of Value in Health: An ISPOR Report,” was published in the May 2025 issue of Value in Health.

Redefining Value in Care for Alzheimer's Disease and Dementia

Apr 8, 2025

Value in Health, the official journal of ISPOR—The Professional Society for Health Economics and Outcomes Research, announced the publication of a special themed section of research papers that provide crucial insights into the complex health economics of Alzheimer's disease and related dementias (ADRD), offering a roadmap for future research and policy as the aging population grows and novel treatments emerge.
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×